Medtronic (NYSE:MDT) said its Endurant abdominal aortic aneurysm stent is performing well, according to a 5-year follow-up study of the device. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago last Saturday. The 5-year, 150-patient study data reported a 99.2% freedom from aneurysm related mortality and an 89% freedom from secondary […]
Medtronic
Two a day: Medtronic acquires Aptus Endo for $110m
Medtronic (NYSE:MDT) announced its 2nd acquisition of the day this afternoon, saying it paid $110 million to acquire Aptus Endosystems and its Heli-FX device aortic securement device. Earlier today the Fridley, Minn.-based medical device giant said it picked up CardioInsight for $93 million. “We are excited to add this unique complementary, anchor technology to our aortic portfolio,” aortic […]
Medtronic puts up $93m for CardioInsight
Medtronic (NYSE:MDT) said today that it paid $93 million for CardioInsight Technologies and its heart-mapping technology. Cleveland-based CardioInsight makes the ECVue, a non-invasive electrocardiographic mapping device that uses body surface electrical data and anatomical data to reconstruct and display 3-D maps and “other useful measures” of the heart’s electrical activity, Medtronic said. The deal includes a $75 million cash payment and a $25 million loan, according […]
UPDATE: Medtronic reveals stake in Arsenal AAA
Medtronic (NYSE:MDT) this week said it took out a stake with an exclusive option to buy in Arsenal Medical subsidiary Arsenal AAA. Arsenal AAA is developing a hemostatic foam and delivery system designed to reduce the chance of endoleaks after the placement of a stent graft to treat an abdominal aortic aneurysm. Arsenal president & CEO Maria Palasis told MassDevice.com that the product is designed […]
Medtronic reveals stake in Arsenal AAA
Medtronic (NYSE:MDT) yesterday said it took out a stake with an option to buy on Arsenal Medical subsidiary Aresenal AAA and its hemostatic foam.* Arsenal AAA is developing the foam and a delivery system that are designed to reduce the chance of endoleaks after the placement of a stent graft to treat an abdominal aortic aneurysm. Financial terms […]
TAVI: Boston Scientific’s Lotus valve tops Medtronic’s CoreValve – study
Data from a study of Boston Scientific‘s (NYSE:BSX) Lotus Valve showed a greater device success rate than Medtronic‘s (NYSE:MDT) CoreValve in high-risk transcatheter aortic valve replacement patients. The single-center, non-randomized study, published this month in the journal JACC: Cardiovascular Interventions, compared outcomes from 50 high-risk TAVI patients treated with the Lotus valve and 50 similar patients treated with Medtronic’s self-expanding CoreValve […]
Diabetes: Medtronic furthers the quest for an artificial pancreas
Medtronic (NYSE:MDT) and Intarcia Therapeutics were in the spotlight at the American Diabetes Assn.’s annual scientific sessions conference in Boston last week, revealing new medical device developments in the fight against diabetes. Medtronic took center stage, announcing new developments for its artificial pancreas program, touting positive data from a user study of its MiniMed 640g and revealing plans to collaborate […]
Medtronic launches Fortrex PTA balloon catheter in US
Medtronic (NYSE:MDT) said yesterday that it launched its Fortrex percutaneous transluminal angioplasty balloon catheter in the U.S. The Fortrex is designed to treat peripheral artery disease and maintain arteriovenous access for hemodialysis, the Fridley, Minn.-based company said. The catheter uses a balloon to break up plaque blockages in the peripheral vascular system, or blockages in hemodialysis […]
Medtronic releases new bariatric surgery device
Medtronic (NYSE:MDT) said it launched the GastriSail, a new device designed to improve consistency and efficiency during sleeve gastrectomy procedures, in the U.S. Sleeve gastrectomies are the most popular weight loss procedures in the U.S. right now, GastriSail co-developer Dr. Amit Trivedi of the Hackensack University Medical Center in N.J. told MassDevice.com. Trivedi said he was inspired […]
Bayer sells Diabetes Care business to Panasonic Healthcare
(Reuters) — Bayer‘s (ETR:BAYN) has agreed to sell its Diabetes Care business to Panasonic Healthcare Holdings, backed by KKR (NYSE:KKR) and Panasonic (NYSE:PC), for 1.02 billion euros ($1.15 billion), the company said on Wednesday. The deal, expected to be completed in the first quarter of 2016, marks Bayer’s second attempt to divest the blood glucose monitoring […]
Diabetes: Medtronic partners with Samsung, Glooko; wins 510(k) for MiniMed Connect
Medtronic (NYSE:MDT) today announced a slew of developments from its diabetes treatment arm, including FDA clearance of its MiniMed Connect diabetes monitoring system; a partnership with Samsung Electronics (LON:BC94) to develop technology for diabetes management; and an agreement with diabetes-monitoring platform developer Glooko. The announcements were made at the American Diabetes Assn.’s annual meeting in Boston. […]
